Redefiniendo la severidad de las exacerbaciones de asma: implicaciones y limitaciones del consenso ALAT-SEPAR

The Global Asthma Report 2022. Int J Tuberc Lung Dis 2022;26(Supp 1):1-104. https://doi.org/10.5588/ijtld.22.1010

Stucky BD, Sherbourne CD, Edelen MO, Eberhart NK. Understanding asthma-specific quality of life: moving beyond asthma symptoms and severity. Eur Respir J 2015;46(3):680-7. https://doi.org/10.1183/09031936.00225014

CDC. AsthmaStats: asthma-related missed school days among children aged 5–17 years. [Internet]. [Consultado 11 feb 2025]. Disponible en: https://www.cdc.gov/asthma/asthma_stats/missing_days.htm

Nurmagambetov T, Kuwahara R, Garbe P. The Economic Burden of Asthma in the United States, 2008-2013. Ann Am Thorac Soc 2018;15(3):348-356. https://doi.org/10.1513/annalsats.201703-259oc

Cruz Á, Stelmach R, Ponte EV. Asthma prevalence and severity in low-resource communities. Curr Opin Allergy Clin Immunol 2017;17(3):188-193. https://doi.org/10.1097/aci.0000000000000360

Forno E, Brandenburg DD, Castro-Rodriguez JA et al. Asthma in the Americas: An Update: A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and American Thoracic Society. Ann Am Thorac Soc 2022;19(4):525-535. https://doi.org/10.1513/annalsats.202109-1068cme

Reddel HK, Taylor DR, Bateman ED et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180(1):59-99. https://doi.org/10.1164/rccm.200801-060st

Stok AM, Álvarez Gutiérrez F, Bellini L et al. Consenso ALAT-SEPAR sobre la definición y clasificación de las exacerbaciones del asma según su gravedad: hacia una estandarización internacional. Respirar 2025;17(4):385-422. https://doi.org/10.55720/respirar.17.4.2

Fitch KBS, Bernstein SJ, Aguilar MD et al. The Rand/UCLA appropriateness method user's manual. Santa Monica: RAND2001. [Internet]. [Consultado 11 feb 2025]. Disponible en: https://www.rand.org/pubs/monograph_reports/MR1269.html

Wechsler ME, Yawn BP, Fuhlbrigge AL et al. Anticholinergic vs Long-Acting beta-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. JAMA 2015;314(16):1720-30. https://doi.org/10.1001/jama.2015.13277

Gorelick MH, Stevens MW, Schultz TR, Scribano PV. Performance of a novel clinical score, the Pediatric Asthma Severity Score (PASS), in the evaluation of acute asthma. Acad Emerg Med 2004;11(1):10-8. https://doi.org/10.1197/j.aem.2003.07.015

Ducharme FM, Chalut D, Plotnick L et al. The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr 2008;152(4):476-80,480.e1. https://doi.org/10.1016/j.jpeds.2007.08.034

Cloutier MM, Baptist AP, Blake KV et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol 2020;146(6):1217-1270. https://doi.org/10.1016/j.jaci.2020.10.003

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2025. Updated May 2025. [Internet]. [Consultado 11 feb 2025]. Disponible en: https://ginasthma.org/2025-gina-strategy-report/

Maldonado-Puebla M, Akenroye A, Busby J, Cardet JC, Louisias M. Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally. J Allergy Clin Immunol Pract 2024;12(2):272-280. https://doi.org/10.1016/j.jaip.2023.11.005